Lupin Limited announced the launch of the book titled “Made in India – The story of Desh Bandhu Gupta, Lupin and Indian Pharma” in Mumbai on February 9, 2026. The book traces the rise of India’s pharma industry, the evolution of Lupin, and the life of its founder, Desh Bandhu Gupta. It highlights how India became the world’s pharmacy through visionary entrepreneurship, detailing struggles, achievements, and the pivotal role of Mrs. Manju Gupta.
Book Launch Highlighting Lupin’s History
Lupin Limited is pleased to announce the launch of its newly released book, “Made in India – The story of Desh Bandhu Gupta, Lupin and Indian Pharma,” which premiered in Mumbai on February 9, 2026. The publication, authored by Sundeep Khanna and Manish Sabharwal, chronicles three intertwined narratives: the growth of the Indian pharmaceutical industry, the birth and progression of Lupin, and the extraordinary life of its founder, Desh Bandhu Gupta (DBG).
A Journey from Adversity to Global Leader
The book illuminates how India transitioned from being entirely reliant on imported medicines to becoming the “world’s pharmacy.” It specifically details DBG’s journey, describing him as a village boy from Rajasthan who overcame adversity without privilege to build a multibillion-dollar enterprise whose medicines now serve patients in over 120 countries. The narrative emphasizes his transformation from a teacher and professor to a business icon.
Written candidly by TeamLease Services co-founder Manish Sabharwal and journalist Sundeep Khanna, the book confronts the failures, financial crises, and personal toll of leadership involved in establishing one of the world’s largest generics firms. It also spotlights the crucial role played by DBG’s wife, Manju Gupta, in supporting the trials and triumphs of building Lupin.
India’s Pharmaceutical Prowess
The release emphasizes India’s current standing, noting that nearly half of the 400 billion pills consumed annually in the US are made in India, as are 60 per cent of the world’s vaccines. The volume discusses the collective impact of Indian pharma pioneers—including DBG of Lupin—who demolished the myth that multinationals hold insurmountable advantages.
Industry Praise for DBG
The launch event featured discussions with leading industry figures. Dilip Sanghvi of Sun Pharma praised DBG as a visionary whose relentless focus on excellence shaped India’s journey to becoming the world’s pharmacy. Similarly, Yusuf Hamied of Cipla commended DBG for building Lupin from modest beginnings with deep commitment to patients, showing how one individual’s purpose can make healthcare accessible globally.
About Lupin Limited
Lupin Limited is a global pharmaceutical leader based in Mumbai, distributing products in over 120 markets. The company specializes in branded and generic formulations, complex generics, and biotechnology products. Lupin employs over 24,000 professionals globally and is committed to improving patient health outcomes through its subsidiaries, including Lupin Diagnostics and Lupin Digital Health.
Source: BSE
